176 related articles for article (PubMed ID: 9191533)
1. Association between human cancer and two polymorphisms occurring together in the p21Waf1/Cip1 cyclin-dependent kinase inhibitor gene.
Facher EA; Becich MJ; Deka A; Law JC
Cancer; 1997 Jun; 79(12):2424-9. PubMed ID: 9191533
[TBL] [Abstract][Full Text] [Related]
2. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
[TBL] [Abstract][Full Text] [Related]
3. WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.
Lukas J; Groshen S; Saffari B; Niu N; Reles A; Wen WH; Felix J; Jones LA; Hall FL; Press MF
Am J Pathol; 1997 Jan; 150(1):167-75. PubMed ID: 9006333
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
5. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
Shi Y; Zou M; Farid NR; al-Sedairy ST
Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
[TBL] [Abstract][Full Text] [Related]
6. Multiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours.
Koopmann J; Maintz D; Schild S; Schramm J; Louis DN; Wiestler OD; von Deimling A
Br J Cancer; 1995 Nov; 72(5):1230-3. PubMed ID: 7577473
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the chemosensitivity of head and neck cancer cells based on the diverse function of mutated-p53.
Shinagawa Y; Kawamata H; Omotehara F; Nakashiro K; Hoque MO; Furihata T; Horiuchi H; Imai Y; Fujimori T; Fujibayashi T
Int J Oncol; 2003 Feb; 22(2):383-9. PubMed ID: 12527938
[TBL] [Abstract][Full Text] [Related]
8. Lack of evidence of association of p21WAF1/CIP1 polymorphism with lung cancer susceptibility and prognosis in Taiwan.
Shih CM; Lin PT; Wang HC; Huang WC; Wang YC
Jpn J Cancer Res; 2000 Jan; 91(1):9-15. PubMed ID: 10744039
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer.
Gao X; Chen YQ; Wu N; Grignon DJ; Sakr W; Porter AT; Honn KV
Oncogene; 1995 Oct; 11(7):1395-8. PubMed ID: 7478562
[TBL] [Abstract][Full Text] [Related]
10. Reduced messenger RNA expression level of p21 CIP1 in human colorectal carcinoma tissues and its association with p53 gene mutation.
Matsushita K; Kobayashi S; Kato M; Itoh Y; Okuyama K; Sakiyama S; Isono K
Int J Cancer; 1996 Aug; 69(4):259-64. PubMed ID: 8797864
[TBL] [Abstract][Full Text] [Related]
11. p21WAF1/CIP1 gene DNA sequencing and its expression in human osteosarcoma.
Liao WM; Zhang CL; Li FB; Zeng BF; Zeng YX
Chin Med J (Engl); 2004 Jun; 117(6):936-40. PubMed ID: 15198903
[TBL] [Abstract][Full Text] [Related]
12. Analysis of p21WAF1/CIP1 in primary bladder tumors.
Lacombe L; Orlow I; Silver D; Gerald WL; Fair WR; Reuter VE; Cordon-Cardo C
Oncol Res; 1996; 8(10-11):409-14. PubMed ID: 9114433
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer.
Li YJ; Laurent-Puig P; Salmon RJ; Thomas G; Hamelin R
Oncogene; 1995 Feb; 10(3):599-601. PubMed ID: 7845685
[TBL] [Abstract][Full Text] [Related]
14. [Expression of p21 WAF1/CIP1 protein in colorectal cancers: study of its relation to p53 mutation and Ki67 antigen expression].
Chapusot C; Assem M; Martin L; Chalabreyssse L; Benhamiche AM; Lignier MA; Chauffert B; Teyssier JR; Faivre J; Piard F
Pathol Biol (Paris); 2001 Mar; 49(2):115-23. PubMed ID: 11317955
[TBL] [Abstract][Full Text] [Related]
15. p21 Waf1/Cip1 polymorphisms and risk of esophageal cancer.
Yang W; Qi Q; Zhang H; Xu W; Chen Z; Wang L; Wang Y; Dong X; Jiao H; Huo Z
Ann Surg Oncol; 2010 May; 17(5):1453-8. PubMed ID: 20112071
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat.
Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ
Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505
[TBL] [Abstract][Full Text] [Related]
17. Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis.
Cho JH; Kim WH
Pathol Res Pract; 1998; 194(5):309-17. PubMed ID: 9651943
[TBL] [Abstract][Full Text] [Related]
18. Novel polymorphism in p21(waf1/cip1) cyclin dependent kinase inhibitor gene: association with human esophageal cancer.
Bahl R; Arora S; Nath N; Mathur M; Shukla NK; Ralhan R
Oncogene; 2000 Jan; 19(3):323-8. PubMed ID: 10656678
[TBL] [Abstract][Full Text] [Related]
19. A protective role for common p21WAF1/Cip1 polymorphisms in human ovarian cancer.
Milner BJ; Brown I; Gabra H; Kitchener HC; Parkin DE; Haites NE
Int J Oncol; 1999 Jul; 15(1):117-9. PubMed ID: 10375603
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 and p21WAF1/CIP1 proteins in gastric and esophageal cancers: comparison with mutations of the p53 gene.
Seta T; Imazeki F; Yokosuka O; Saisho H; Suzuki T; Koide Y; Isono K
Dig Dis Sci; 1998 Feb; 43(2):279-89. PubMed ID: 9512119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
